Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

12. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3041


	Artikel 1 - 20 / 60811

	Assessing collagenase-a and type-II mediated degradation of human type-I collagen by photoacoustic spectroscopy toward clinical translation in cancer progression. Sci Rep Biswas S, Chandra S, Bhat G, Mathew S, Murali TS, Mahato KK. PMID: 42436335 [PubMed - as supplied by publisher]
	Hydrogel-based platforms for localized cancer treatment: Design strategies for precision therapeutic delivery. J Control Release Salathia S, Casadidio C, Censi R. PMID: 42435859 [PubMed - as supplied by publisher]
	Prognostic value of lactate dehydrogenase-to-albumin ratio in metastatic/recurrent pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel: a single-center retrospective cohort study. J Gastrointest Oncol Yamauchi Y, Sofuni A, Nagakawa Y, Itoi T. PMID: 42434227 [PubMed]
	From pancreatic ductal adenocarcinoma to non-small cell lung cancer: daraxonrasib in the RASolute 302 trial - a pan-RAS(ON) breakthrough or the next evolution in targeting diverse oncogenic RAS variants? Ann Med Surg (Lond) Qaseem M, Ali MS, Ali S, Hasan AH. PMID: 42433811 [PubMed]
	Dietary fatty acid intake and the risk of pancreatic cancer: a dose-response meta-analysis of observational studies. Ann Med Surg (Lond) Al Masri MK, Hasan MK, Ali SA, Alsubaiei AA, Ali SA, AlMaazmi AM, Saleh SAK, Adly HM, Kutbi E, AlJurayyan AN, Abu-Zaid A. PMID: 42433782 [PubMed]
	Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective Study. Liver Cancer Ye L, Liu GX, Yang DL, Zeng FJ, Liu J, Yao HB, Nong JL, Liu SP, Peng N, Li WF, Wu PS, Qin C, Su Z, Ou JJ, Dong XF, Yan YH, Zhong TM, Wu MS, Chen YZ, Wang GD, Li MJ, Wang XY, Yang FQ, Chen SC, Yang YY, Chen K, Lai YC, Pang QQ, Liang XM, Mao XS, Liang YR, Li FX, Shi H, Li RJ, Xiang BD, Ma L, Zhong JH, Yu YQ, GUIDANCE investigators. PMID: 42433265 [PubMed - as supplied by publisher]
	Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage. Dig Endosc Tamura T, Matsumori T, Nishikawa Y, Kitagawa K, Nagai M, Shimizu A, Matsumoto I, Masuda A, Sakai A, Yamai T, Tomokuni A, Ikeura T, Ito T, Doi T, Miyake H, Maruyama H, Ishikawa-Kakiya Y, Ogura T, Ueno S, Shiomi H, Tsujimoto A, Shintani S, Ikeda T, Uenoyama Y, Emori T, Shimatani M, Hanada K, Kitano M, Takenaka M. PMID: 42433174 [PubMed - indexed for MEDLINE]
	Rectal Adenocarcinoma With Enteroblastic Differentiation and Hepatic Metastases: A Rare and Aggressive Variant of Colorectal Carcinoma. Am J Case Rep Syed FF, Khalid A. PMID: 42432994 [PubMed - indexed for MEDLINE]
	Solid serous adenoma of the pancreas mimicking a solid pseudopapillary neoplasm: A case report. Medicine (Baltimore) Jin S, Lee J, Cho BS, Yi KS, Kim Y, Choi CH, Woo CG. PMID: 42432909 [PubMed - indexed for MEDLINE]
	Redox-senescence function of PON1 in hepatocellular carcinoma and its non-invasive assessment using super-resolution radiomics: a multi-center study. J Transl Med Cai C, Hao Y, Xue Y, Li D, Wang Y, Yue X, Hou J, Wang Z, Li BY, Xie M, Zhuang H, Li D, Ding X. PMID: 42432749 [PubMed - as supplied by publisher]
	Factors contributing to the missed diagnosis of incidental gallbladder cancer (IGBC): an integrated analysis of clinical features and ultrasound radiomics. BMC Cancer Pan Z, Sun X, Shen Z, Cen F, Yan Q. PMID: 42432566 [PubMed - as supplied by publisher]
	Identification of therapeutic targets and postoperative recurrence prediction model construction for hepatocellular carcinoma based on systematic mendelian randomization. Arab J Gastroenterol Kong Y, Wang Y, Yang Q, Ye S. PMID: 42431780 [PubMed - as supplied by publisher]
	Preclinical evidence for cytokine-based immunotherapy in pancreatic cancer treatment: A systematic review. Int J Biol Macromol Rodríguez-Criado J, Corona-Castro AJ, Quiñonero F, Prados J, Melguizo C. PMID: 42431486 [PubMed - as supplied by publisher]
	Challenges in Venous Thromboembolism Risk Stratification After Pancreatic and Liver Cancer Surgery Using Claims Data. J Surg Oncol Dong K, Fuccello A, Vyas V, Fong ZV, Schootman M, Martin BC, Mavros MN. PMID: 42429123 [PubMed - indexed for MEDLINE]
	Genetic Links Between Cancer and Coronary Atherosclerosis: A Mendelian Randomization Analysis. Hum Mutat Fan Y, Liu M, Zhang L, Liu F, Dong J, Zhang M, Zhang L, Sun Y, Yao W, Geng W. PMID: 42428245 [PubMed - indexed for MEDLINE]
	Sugar sweetened and artificially sweetened beverages, fruit and vegetable juices and cancer risk: a World Cancer Research Fund International Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. medRxiv Jayedi A, Markozannes G, Kazmi SZ, Cariolou M, Vieira R, Kiss S, Balducci K, Pagkalidou E, Cividini S, Aune D, Greenwood DC, Dossus L, Fontvieille E, Ahmadi N, Mahamat-Saleh Y, Cross AJ, Gunter MJ, Zürn SJ, Abnet CC, Ferrari P, Gordon-Dseagu VLZ, Maskell K, Clary C, Croker H, Mitrou P, Riboli E, Baskin M, Chowdhury R, Gaudet M, Giovannucci E, Kampman E, Lewis SJ, May AM, Park Y, Pischon T, Severi G, Hill L, Weijenberg MP, Krebs J, Tsilidis KK, Chan DSM. PMID: 42428101 [PubMed]
	Toward point-of-care cancer diagnostics: gold nanoparticle-based colorimetric sensors. RSC Adv Sultana E, Mamun MSA. PMID: 42427407 [PubMed - as supplied by publisher]
	KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS(G12D)-mutant pancreatic cancer: a phase 1b/2 trial. Nat Med Cui J, Jiang K, Li W, Ni S, Zong H, Du J, He Y, Liu Z, Kong G, Zhang Y, Li X, Han H, Yao F, Chen Y, Zhou M, Wang L. PMID: 42426224 [PubMed - as supplied by publisher]
	Optimizing media composition for patient-derived organoids in ovarian cancer: a narrative review. Chin Clin Oncol Hanna K, Castrillón Sánchez M, Levin G, Akiki G, Tessier-Cloutier B, Leung SOA. PMID: 42425776 [PubMed - indexed for MEDLINE]
	Response to Letter to the Editor: 'NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial'. ESMO Open Macarulla T, Cid RP, Womack MS, Gracian AC, Zervoudakis A, Hatoum H, Chung V, Patel A, Paulson AS, Pant S, O'Reilly EM, Hubner RA, Van Cutsem E, Bekaii-Saab T, Zhang L, Li J, Chen H, Maxwell F, Wainberg ZA, Melisi D. PMID: 42424906 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 60811

Seite 1 von 3041



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung